BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu HHL, Rakisheva A, Ponnusamy A, Chinnadurai R. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity? World J Gastroenterol 2024; 30(2): 128-136 [PMID: 38312119 DOI: 10.3748/wjg.v30.i2.128]
URL: https://www.wjgnet.com/1948-5182/full/v30/i2/128.htm
Number Citing Articles
1
V. L. Korobka, Yu. V. Khoronko, R. V. Korobka, E. V. Kosovtsev, M. V. Malevanny, E. S. Pak, E. V. Tadieva. Transjugular intrahepatic portosystemic shunting in patients over 60 years with cirrhosis and comorbidities when liver transplantation is reasonably deniedAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2024; 29(3): 40 doi: 10.16931/31/1995-5464.2024-3-40-49
2
Jacopo BELFIORE, Michele CHECCHI, Niccolò CASTELLANI NICOLINI, Pietro BERTINI, Dmitri BEZINOVER, Lorenzo DE MARCHI, Giandomenico BIANCOFIORE. Transesophageal echocardiography monitoring for liver transplantation: where are we now?Minerva Anestesiologica 2025; 91(10) doi: 10.23736/S0375-9393.24.18483-0
3
Sheng-Hao Li, Lu Zhang, Hong-Juan Li, Ye Li, Yan-Min Zheng, Qing-Qing Wang. Left Ventricular Diastolic Dysfunction Increases the Risk of Medium-term Mortality in Patients with Cirrhotic AscitesRomanian Journal of Internal Medicine 2025;  doi: 10.2478/rjim-2025-0022
4
V. Rudyashko. Changes in urine properties in dogs with combined liver and kidney diseaseScientific Messenger of LNU of Veterinary Medicine and Biotechnologies 2025; 27(119): 203 doi: 10.32718/nvlvet11928
5
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicineFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381476
6
Jacob J. Gries, Bing Chen, Meena B. Bansal, Mario Rodriguez, Saleh A. Alqahtani, Paul N. Brennan, Chim C. Lang, W. H. Wilson Tang, Jeffrey V. Lazarus, Chayakrit Krittanawong. Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver diseaseCommunications Medicine 2025; 5(1) doi: 10.1038/s43856-025-00951-2
7
Karel Kostev, Jamschid Sedighi, Samuel Sossalla, Marcel Konrad, Mark Luedde. Both Alcoholic and Non-Alcoholic Liver Cirrhosis Are Associated with an Increased Risk of HF—A Cohort Study Including 75,558 PatientsJournal of Cardiovascular Development and Disease 2025; 12(8): 295 doi: 10.3390/jcdd12080295
8
Ramadan A. Saad, Mai Tarek, Howaida S. Ali, Wael M. Elayat, Abd El-Hamid A. Mohamed. Vitamin D3 Ameliorates BDL-Induced Hepatocardiac Abnormalities. Possible Role of IGF-1Journal of Evolutionary Biochemistry and Physiology 2025; 61(1): 327 doi: 10.1134/S0022093024600519
9
Lavinia Alice Bălăceanu, Cristiana Grigore, Ion Dina, Cristian-Dorin Gurău, Mara Mădălina Mihai, Beatrice Bălăceanu-Gurău. CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic ConsiderationsJournal of Clinical Medicine 2025; 14(12): 4152 doi: 10.3390/jcm14124152
10
Dae Gon Ryu, Fengxue Yu, Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic CardiomyopathyReviews in Cardiovascular Medicine 2024; 25(12) doi: 10.31083/j.rcm2512457
11
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
12
John Nzobokela, Lweendo Muchaili, Alick Mwambungu, Sepiso K. Masenga, Annet Kirabo. Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndromeFrontiers in Cardiovascular Medicine 2025; 12 doi: 10.3389/fcvm.2025.1661563